Rani Therapeutics Holdings, Inc.
RANI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4 | $6 | $27 | $117 |
| Short-Term Investments | $24 | $43 | $71 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $2 | $2 | $2 |
| Total Curr. Assets | $30 | $51 | $101 | $120 |
| Property Plant & Equip (Net) | $7 | $7 | $7 | $5 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $7 | $7 | $7 | $5 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $37 | $58 | $108 | $124 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $1 | $1 |
| Short-Term Debt | $16 | $6 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $1 | $0 | $0 |
| Other Curr. Liab. | $2 | $1 | $2 | $2 |
| Total Curr. Liab. | $20 | $8 | $5 | $3 |
| LT Debt | $13 | $24 | $29 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $13 | $24 | $29 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $1 | $1 | $0 |
| Total Liabilities | $33 | $32 | $34 | $3 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$103 | -$73 | -$39 | -$8 |
| AOCI | $0 | -$0 | -$0 | -$0 |
| Other Equity | $105 | $86 | $76 | $56 |
| Total Equity | $2 | $13 | $37 | $47 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $2 | $13 | $37 | $74 |
| Total Liab. & Tot. Equity | $37 | $58 | $108 | $124 |
| Net Debt | $26 | $24 | $3 | -$117 |